Treatment strategies for colorectal cancer patients in tumor hospitals under the background of corona virus disease 2019;新型冠状病毒肺炎背景下的肿瘤医院结直肠癌患者诊疗策略

Chinese Journal of Gastrointestinal Surgery / Zhonghua Wei Chang Wai Ke Za Zhi

Volumn 23, Issue 3, 2020, Pages 201-208

  Hu, Xuhua ^a   Niu, Wenbo ^a   Zhang, Jianfeng ^a   Li, Baokun ^a   Yu, Bin ^a   Zhang, Zhenya ^a   Zhou, Chaoxi ^a   Zhang, Xuena ^a   Gao, Yang ^a   Wang, Guiying ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

2019 nCoV; Colorectal neoplasms; Corona virus disease 2019; Treatment strategy

Indexed keywords

COVID-19;

COLORECTAL TUMOR; COMPLICATION; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; EARLY CANCER DIAGNOSIS; EPIDEMIC; HUMAN; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA;

COLORECTAL NEOPLASMS; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; EARLY DETECTION OF CANCER; HUMANS; PNEUMONIA, VIRAL;

EID: 85082033400     PISSN: 16710274     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.cn.441530-20200217-00058     Document Type: Article

References (22)

1. Lu RG，Zhao X，Li J，et al. Genomic characterisation and epidemiology of 2019 novel coronavirus：implications for virus origins a nd receptor binding[J]. Lancet，2020，In Press. DOI：10.1016/S0140-6736（20）30251-8.
2. 中华预防医学会新型冠状病毒肺炎防控专家组.新型冠状病毒肺炎流行病学特征的最新认识[J]. 中华流行病学杂志，2020，41（2）：139-144.
3. Li Q，Guan X，Wu P，et al. Early Transmission Dynamics in Wuhan，China，of novel coronavirus-infected pneumonia[J]. N Engl J Med，2020，In Press. DOI：10.1056/NEJMoa2001316.
4. Wu JT，Leung K，Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019 - nCoV outbreak originating in Wuhan，China：a modelling study[J]. Lancet，2020，In Press. DOI：10.1016/S0140-6736（20）30260-9.
5. Siegel RL，Miller KD，Jemal A. Cancer statistics，2020[J]. CA Cancer J Clin，2020，70（1）：7-30.DOI：10.3322/caac.21590.
6. 郑荣寿，孙可欣，张思维，等 . 2015 年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志，2019，41（1）：19-28. DOI：10.3760/cma. j.issn.0253-3766.2019.01.008.
7. 张鹏，陶凯雄 . 在新型冠状病毒感染的肺炎疫情下普外科医师面临挑战及对策[J]. 中国实用外科杂志，2020.
8. Chan PK，To KF，Lo AW，et al. Persistent infection of SARS coronavirus in colonic cells in vitro[J]. J Med Virol，2004，74 （1）：1-7. DOI：10.1002/jmv.20138.
9. 杨智炜，李干文，戴小灵，等. 新型冠状病毒肺炎咽拭子转阴但粪便核酸检测仍阳性三例[J]. 中华消化杂志，2020，40（00）：E002. DOI：10.3760/cma.j.issn.0254-1432.2020.0002.
10. Liang W，Guan W，Chen R，et al. Cancer patients in SARS-Cov-2 infection：a nationwide analysis in china[J]. Lancet Oncol，2020，In Press. DOI：10.1016/S1470-2045（20）30096-6.
11. Ribeiro MS，Wallace MB. Endoscopic treatment of early cancer of the colon[J]. Gastroenterol Hepatol（NY），2015，11（7）：445-452.
12. Tanaka S，Kashida H，Saito Y，et al. JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection[J]. Dig Endosc，2015，27（4）：417-434. DOI：10.1111/ den.12456.
13. Seymour MT，Morton DFOxTROT：an international randomised controlled trial in 1052 patients （pts） evaluating neoadjuvant chemotherapy（NAC）for colon cancer[J]. J Clin Oncol，2019，37 Suppl 15：S3504.
14. Liu F， Yang L， Wu Y， et al. CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients：a prospective single - arm phase II trial[J]. Chin J Cancer Res，2016，28（6）：589-597. DOI：10.21147/j.issn.1000-9604.2016.06.05.
15. Cercek A，Roxburgh CSD，Strombom P，et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer[J]. JAMA Oncol，2018，4（6）：e180071.
16. Pisano M，Zorcolo L，Merli C，et al. 2017 WSES guidelines on colon and rectal cancer emergencies：obstruction and perforation [J]. World J Emerg Surg，2018，13：36. DOI：10.1186/s13017-018-0192-3.
17. Xu RH， Muro K， Morita S， et al. Modified XELIRI （capecitabine plus irinotecan） versus FOLFIRI （leucovorin，fluorouracil， and irinotecan）， both either with or without bevacizumab，as second - line therapy for metastatic colorectal cancer（AXEPT）：a multicentre，open-label，randomised，noninferiority，phase 3 trial[J]. Lancet Oncol，2018，19（5）：660-671. DOI：10.1016/S1470-2045（18）30140-2.
18. Luo HY，Li YH，Wang W，et al. Single - agent capecitabine as maintenance therapy after induction of XELOX（or FOLFOX）in first - line treatment of metastatic colorectal cancer：randomized clinical trial of efficacy and safety[J]. Ann Oncol，2016，27（6）：1074-1081. DOI：10.1093/annonc/mdw101.
19. Tey J， Leong CN， Cheong WK， et al. A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy （IMRT） for locally advanced rectal cancer[J]. J Cancer，2017，8（16）：3114 - 3121. DOI：10. 7150/jca.21237.
20. Renehan AG，Malcomson L，Emsley R，et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer（the OnCoRe project）：a propensity-score matched cohort analysis[J]. Lancet Oncol，2016，17（2）：174-183. DOI：10.1016/S1470-2045（15）00467-2.
21. Iveson T，Sobrero AF，Yoshino T，et al. Prospective pooled analysis of four randomized trials investigating duration of adjuvant（adj）oxaliplatin-based therapy（3 vs 6 months｛m｝）for patients（pts）with high-risk stage II colorectal cancer（CC）[J]. J Clin Oncol，2019，37：3501.
22. Chen G，Li J. Duration of adjuvant chemotherapy for stage iii colon cancer[J]. N Engl J Med，2018，379（4）：395-396.DOI：10.1056/NEJMc1805498.